Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2022-03-18 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
Own shares - NL.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details specific transactions where UCB shares were transferred to employees as part of long-term incentive plans (stock options). This activity directly relates to the company managing its own share capital, specifically through the issuance or transfer of shares related to employee compensation schemes. This aligns precisely with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities. The document is a formal announcement (Gereglementeerde informatie) detailing these transactions, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the core data itself.
2022-03-18 Dutch
Own shares - 11.03.22 - ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Disposal of own shares" and details transactions where UCB disposed of its own shares OTC following stock option exercises under Long-Term Incentive Programs (LTI). This directly relates to the company buying back or issuing its own shares, which aligns perfectly with the definition of 'Transaction in Own Shares'. The corresponding code is POS. The document is short and appears to be a regulated information press release, but the core subject matter is the share transaction itself, not just an announcement of a report.
2022-03-11 English
Own shares - 11.03.22 - FR.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the content details transactions where UCB SA sold (alienated) its own shares OTC following the exercise of stock options by employees as part of long-term incentive plans (LTI). This directly relates to the company managing its own share capital through repurchase or issuance activities. The definition for 'Transaction in Own Shares' (POS) is: 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. This classification fits perfectly. It is not a general financing update (CAP) or a major shareholding notification (MRQ) which usually concerns external parties crossing thresholds.
2022-03-11 French
Own shares - 11.03.22 - NL.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content details transactions where UCB delivered its own shares to employees as part of long-term incentive plans (stock options and LTI plans). This activity directly relates to the company buying back or issuing its own shares, specifically the issuance/delivery of shares from treasury stock to employees. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement of these transactions, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the specific transaction details.
2022-03-11 Dutch
220307 - Disposals of own shares_ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Disposal of own shares" and details transactions where UCB disposed of its own shares OTC following the exercise of stock options by personnel under various Long-Term Incentive (LTI) plans. This activity directly relates to the company managing its own equity, specifically through share transactions that are not standard open-market purchases (repurchases) but rather issuances/disposals related to employee compensation schemes. This aligns precisely with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities. It is not a general financing update (CAP), a director's dealing (DIRS), or a general regulatory filing (RNS).
2022-03-07 English
220307 - Aliénation d'actions propres_FR.pdf
Director's Dealing Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details transactions where UCB SA alienated (sold/transferred) its own shares, primarily due to the exercise of stock options by employees as part of long-term incentive plans (LTI). It explicitly mentions the date of the announcement (March 7, 2022) and the transactions occurring in late February/early March 2022. This type of filing, reporting the company's own share transactions (repurchases or issuance/transfer related to compensation), directly corresponds to the definition of 'Transaction in Own Shares'.
2022-03-07 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.